ROBINSON CHANDLER (Chief Executive Officer) reported 1 transaction at MONOPAR THERAPEUTICS
Review the transaction codes below to understand the nature of each event.
Filed: 1/30/2026ACC: 0001437749-26-002527
DirectorOfficer10% Owner· Chief Executive Officer
Since Aug 2018
+62.81K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
62.81K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+62.81K
Price / share
—
Trade value
—
% of position
New position
1/28/2025
0.00→62.81K
Total
Net shares
+62.81K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/28/2025 | J · J | +62.81K | — | — | New position | 0.00 | 62.81K |
| Total | +62.81K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned85.72K
Total
85.72K direct85.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 85.72K | Direct |
| Total | 85.72K | 85.72K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported